Acute Lymphoblastic Leukemia News Archives - SOHO Insider

Skip to content

Phase 1b trial reports promising outcomes with olverembatinib plus blinatumomab in relapsed or refractory CML or ALL
SOHO 2026 posters not to miss: MPN edition with Dr. Gabriela Hobbs
Young investigators define the SOHO difference
Dr. Jerald Radich highlights meaningful posters in CML at SOHO 2026
The state of SOHO: a year of growth and opportunity

Insider Reader Survey

Join SOHO

Follow Us :

Insider Podcast
Society Updates/Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

Selina Luger, MD, weighs the promise and challenges of modern ALL care

Cellular Therapy

Selina Luger, MD, weighs the promise and challenges of modern ALL care

Leukemia

Selina Luger, MD, weighs the promise and challenges of modern ALL care

Lymphoma

Selina Luger, MD, weighs the promise and challenges of modern ALL care

Multiple Myeloma

Selina Luger, MD, weighs the promise and challenges of modern ALL care

Myelodysplastic Syndromes

Selina Luger, MD, weighs the promise and challenges of modern ALL care

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

September 21, 2026

Insider Podcast
Society Updates/Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

SOHO Insider Hem/Onc Library Meetings / Conferences SOHO 2026 Acute Lymphoblastic Leukemia News

Acute Lymphoblastic Leukemia News

News and highlights on acute lymphoblastic leukemia from the 14th Annual Meeting of SOHO in Houston.

Acute Lymphoblastic Leukemia News SOHO 2026 Meetings / Conferences

Selina Luger, MD, weighs the promise and challenges of modern ALL care

by Leah Sherwood
September 15, 2026
0 Comments

Doctor holding an ipad

Acute Lymphoblastic Leukemia News SOHO 2026

Obe-cel provides consistent efficacy and safety for relapsed or refractory B-ALL regardless of EMD status

by Patrick Daly
September 11, 2026
0 Comments

Acute Lymphoblastic Leukemia News SOHO 2026

To transplant or not to transplant in pediatric ALL?

by Michael Pulsipher, MD and Rayne H. Rouce, MD
September 9, 2026
0 Comments

Acute Lymphoblastic Leukemia News SOHO 2026 Cellular Therapy Leukemia Acute Lymphoblastic Leukemia Meetings / Conferences News

Session sparks debate on whether chemotherapy is needed in ALL care

by Elias Jabbour, MD
September 7, 2026
0 Comments

Close up of virologist's hands in blue gloves adjusting microscope in laboratory, conducting scientific research and analysis. Health care, medicine and science concept.

Acute Lymphoblastic Leukemia News SOHO 2026 Meetings / Conferences News

Extended analysis shows long-term benefit with obe-cel in relapsed or refractory B-ALL

by Patrick Daly
September 2, 2026
0 Comments

Acute Lymphoblastic Leukemia News Leukemia News SOHO 2026 Cellular Therapy Leukemia Acute Lymphoblastic Leukemia News Video Interviews

Dr. DiPersio previews the SOHO 2026 ALL session to be held on Wednesday, September 9

by SOHO Insider Editors
September 2, 2026
0 Comments

Doctor holding an ipad

Acute Lymphoblastic Leukemia News SOHO 2026 Leukemia Acute Lymphoblastic Leukemia Meetings / Conferences News

TKI discontinuation possible in Ph+ ALL following treatment with blinatumomab and ponatinib

by Kerri Fitzgerald
September 1, 2026
0 Comments

Top Categories

Cellular Therapy

82

Leukemia

134

Lymphoma

141

Multiple Myeloma

120

Myelodysplastic Syndromes

49

Myeloproliferative Neoplasms

36

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

TKI discontinuation possible in Ph+ ALL following treatment with blinatumomab and ponatinib

Cellular Therapy

TKI discontinuation possible in Ph+ ALL following treatment with blinatumomab and ponatinib

Leukemia

TKI discontinuation possible in Ph+ ALL following treatment with blinatumomab and ponatinib

Lymphoma

TKI discontinuation possible in Ph+ ALL following treatment with blinatumomab and ponatinib

Multiple Myeloma

TKI discontinuation possible in Ph+ ALL following treatment with blinatumomab and ponatinib

Myelodysplastic Syndromes

TKI discontinuation possible in Ph+ ALL following treatment with blinatumomab and ponatinib

Myeloproliferative Neoplasms

Subscribe

Recent Posts

Phase 1b trial reports promising outcomes with olverembatinib plus blinatumomab in relapsed or refractory CML or ALL

SOHO 2026 posters not to miss: MPN edition with Dr. Gabriela Hobbs

POWERFUL-400x400

Young investigators define the SOHO difference

Copyright © 2026 Society of Hematologic Oncology, All rights reserved.